Rachel E. Haurwitz's Net Worth
$274 Thousand
Who is Rachel E. Haurwitz?
Rachel E. Haurwitz does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Seer, Inc., Intellia Therapeutics, Inc., and Caribou Biosciences, Inc..
SEC CIK
Rachel E. Haurwitz's CIK is 0001670579
Past Insider Trading and Trends
2022 was Rachel E. Haurwitz's most active year for acquiring shares with 5 total transactions. Rachel E. Haurwitz's most active month to acquire stocks was the month of May. 2022 was Rachel E. Haurwitz's most active year for disposing of shares, totalling 3 transactions. Rachel E. Haurwitz's most active month to dispose stocks was the month of December. 2023 saw Rachel E. Haurwitz paying a total of $59,200.00 for 588,678 shares, this is the most they've acquired in one year. In 2022 Rachel E. Haurwitz cashed out on 30,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Seer, Inc. (SEER) Snapshot price: $1.63
InvestorRachel E. Haurwitz owns 87,615 units of Class A Common Stock which is worth $142,812.45. From 2021 to 2024 Rachel E. Haurwitz acquired a total of 87,615 shares in Seer, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +197.64% | 58.18K |
—
|
—
| 87.61K |
Jun 12
| |||
Form 4
| +391.11% | 23.44K |
—
|
—
| 29.44K |
Jun 14
| |||
Form 4
|
∞
| 5.99K |
—
|
—
| 5.99K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3,100.03% | 5.42M |
—
|
—
| 5.59M |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Caribou Biosciences, Inc. (CRBU) Snapshot price: $1.76
President and CEORachel E. Haurwitz owns 158,700 units of Common Stock which is worth $279,312.00. From 2021 to 2024 Rachel E. Haurwitz acquired a total of 168,700 shares in Caribou Biosciences, Inc. at a cost of $148,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +296.75% | 118.7K |
—
|
—
| 158.7K |
Feb 20
| |||
Form 4
| +33.33% | 10K |
$2.96 | $29,600.00 | 40K |
Jun 8
| |||
Form 4
| +50.00% | 10K |
$2.96 | $29,600.00 | 30K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +100.00% | 10K |
$2.96 | $29,600.00 | 20K |
May 9
| |||
Form 4/A
|
∞
| 10K |
$2.96 | $29,600.00 | 10K |
Jan 26
| |||
Form 4
| +0.30% | 10K |
$2.96 | $29,600.00 | 3.36M |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||